9121 POSTER A Multi-center, Open, Randomized, Phase II Study to Investigate the Sequential Administration of Docetaxel and Intermittent Erlotinib Versus Erlotinib as a Second-line Therapy for Advanced Non-small Cell Lung Cancer (NSCLC)
2011 ◽
Vol 29
(15_suppl)
◽
pp. e18036-e18036
◽
2019 ◽
Vol 14
(5)
◽
pp. 903-913
◽
Keyword(s):
Phase II study of cabazitaxel as second-line therapy in stage IV non-small cell lung cancer (NSCLC).
2014 ◽
Vol 32
(15_suppl)
◽
pp. e19107-e19107
2010 ◽
Vol 28
(15_suppl)
◽
pp. 7580-7580
◽
Keyword(s):
Keyword(s):